Moderna Inc (NASDAQ:MRNA) traded at $110.31 at close of the session on Tuesday, April 30, made a downward move of -1.17% on its previous day’s price.
Looking at the stock we see that its previous close was $111.62 . In terms of its 52-week price range, MRNA has a high of $142.79 and a low of $62.55. The company’s stock has gained about 4.46% over that past 30 days.
Moderna Inc has a market cap of $42.24 billion. Estimates by analysts give the company expected earnings per share (EPS) of -$3.58, with the EPS growth for the year raised at -$7.22 for 2024 and -$5.19 for next year. These figures represent 41.40% and 28.10% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $97.5 million, with a high of $275 million. The median projection represents growth adding up to -94.80% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $4.18 billion, or -39.00% down from figures reported last year.
On the other hand, looking at the outlook for the MRNA stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Looking further, we note the current price level is 4.69% off its SMA20 and 7.47% from its 50-day simple moving average. The RSI (14) is pointing at 58.41 while the volatility over the past week is 3.67% and jumps to 4.36% over the past one month. The beta value is 1.57, while the average true range (ATR) is currently pointing at 4.53.
Coming back to Moderna Inc (NASDAQ:MRNA), we note that the average 3-month trading volume was 3.75 million. Current shares outstanding are 382.00 million.
The insiders hold 12.14% of the company’s shares while institutions hold 67.84%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 10.92% up in year-to-date price movement.
